Serveur d'exploration Stress et Covid

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Lessons from a decade of individual-based models for infectious disease transmission: a systematic review (2006-2015).

Identifieur interne : 000876 ( Ncbi/Merge ); précédent : 000875; suivant : 000877

Lessons from a decade of individual-based models for infectious disease transmission: a systematic review (2006-2015).

Auteurs : Lander Willem [Belgique] ; Frederik Verelst [Belgique] ; Joke Bilcke [Belgique] ; Niel Hens [Belgique] ; Philippe Beutels [Belgique]

Source :

RBID : pubmed:28893198

Descripteurs français

English descriptors

Abstract

Individual-based models (IBMs) are useful to simulate events subject to stochasticity and/or heterogeneity, and have become well established to model the potential (re)emergence of pathogens (e.g., pandemic influenza, bioterrorism). Individual heterogeneity at the host and pathogen level is increasingly documented to influence transmission of endemic diseases and it is well understood that the final stages of elimination strategies for vaccine-preventable childhood diseases (e.g., polio, measles) are subject to stochasticity. Even so it appears IBMs for both these phenomena are not well established. We review a decade of IBM publications aiming to obtain insights in their advantages, pitfalls and rationale for use and to make recommendations facilitating knowledge transfer within and across disciplines.

DOI: 10.1186/s12879-017-2699-8
PubMed: 28893198

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:28893198

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Lessons from a decade of individual-based models for infectious disease transmission: a systematic review (2006-2015).</title>
<author>
<name sortKey="Willem, Lander" sort="Willem, Lander" uniqKey="Willem L" first="Lander" last="Willem">Lander Willem</name>
<affiliation wicri:level="4">
<nlm:affiliation>Centre for Health Economics Research & Modeling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium. lander.willem@uantwerp.be.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Centre for Health Economics Research & Modeling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp</wicri:regionArea>
<orgName type="university">Université d'Anvers</orgName>
<placeName>
<settlement type="city">Anvers</settlement>
<region>Région flamande</region>
<region type="district" nuts="2">Province d'Anvers</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Verelst, Frederik" sort="Verelst, Frederik" uniqKey="Verelst F" first="Frederik" last="Verelst">Frederik Verelst</name>
<affiliation wicri:level="4">
<nlm:affiliation>Centre for Health Economics Research & Modeling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Centre for Health Economics Research & Modeling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp</wicri:regionArea>
<orgName type="university">Université d'Anvers</orgName>
<placeName>
<settlement type="city">Anvers</settlement>
<region>Région flamande</region>
<region type="district" nuts="2">Province d'Anvers</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bilcke, Joke" sort="Bilcke, Joke" uniqKey="Bilcke J" first="Joke" last="Bilcke">Joke Bilcke</name>
<affiliation wicri:level="4">
<nlm:affiliation>Centre for Health Economics Research & Modeling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Centre for Health Economics Research & Modeling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp</wicri:regionArea>
<orgName type="university">Université d'Anvers</orgName>
<placeName>
<settlement type="city">Anvers</settlement>
<region>Région flamande</region>
<region type="district" nuts="2">Province d'Anvers</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Hens, Niel" sort="Hens, Niel" uniqKey="Hens N" first="Niel" last="Hens">Niel Hens</name>
<affiliation wicri:level="4">
<nlm:affiliation>Centre for Health Economics Research & Modeling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Centre for Health Economics Research & Modeling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp</wicri:regionArea>
<orgName type="university">Université d'Anvers</orgName>
<placeName>
<settlement type="city">Anvers</settlement>
<region>Région flamande</region>
<region type="district" nuts="2">Province d'Anvers</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Beutels, Philippe" sort="Beutels, Philippe" uniqKey="Beutels P" first="Philippe" last="Beutels">Philippe Beutels</name>
<affiliation wicri:level="4">
<nlm:affiliation>Centre for Health Economics Research & Modeling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Centre for Health Economics Research & Modeling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp</wicri:regionArea>
<orgName type="university">Université d'Anvers</orgName>
<placeName>
<settlement type="city">Anvers</settlement>
<region>Région flamande</region>
<region type="district" nuts="2">Province d'Anvers</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28893198</idno>
<idno type="pmid">28893198</idno>
<idno type="doi">10.1186/s12879-017-2699-8</idno>
<idno type="wicri:Area/PubMed/Corpus">000310</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000310</idno>
<idno type="wicri:Area/PubMed/Curation">000309</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000309</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000319</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000319</idno>
<idno type="wicri:Area/Ncbi/Merge">000876</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Lessons from a decade of individual-based models for infectious disease transmission: a systematic review (2006-2015).</title>
<author>
<name sortKey="Willem, Lander" sort="Willem, Lander" uniqKey="Willem L" first="Lander" last="Willem">Lander Willem</name>
<affiliation wicri:level="4">
<nlm:affiliation>Centre for Health Economics Research & Modeling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium. lander.willem@uantwerp.be.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Centre for Health Economics Research & Modeling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp</wicri:regionArea>
<orgName type="university">Université d'Anvers</orgName>
<placeName>
<settlement type="city">Anvers</settlement>
<region>Région flamande</region>
<region type="district" nuts="2">Province d'Anvers</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Verelst, Frederik" sort="Verelst, Frederik" uniqKey="Verelst F" first="Frederik" last="Verelst">Frederik Verelst</name>
<affiliation wicri:level="4">
<nlm:affiliation>Centre for Health Economics Research & Modeling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Centre for Health Economics Research & Modeling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp</wicri:regionArea>
<orgName type="university">Université d'Anvers</orgName>
<placeName>
<settlement type="city">Anvers</settlement>
<region>Région flamande</region>
<region type="district" nuts="2">Province d'Anvers</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bilcke, Joke" sort="Bilcke, Joke" uniqKey="Bilcke J" first="Joke" last="Bilcke">Joke Bilcke</name>
<affiliation wicri:level="4">
<nlm:affiliation>Centre for Health Economics Research & Modeling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Centre for Health Economics Research & Modeling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp</wicri:regionArea>
<orgName type="university">Université d'Anvers</orgName>
<placeName>
<settlement type="city">Anvers</settlement>
<region>Région flamande</region>
<region type="district" nuts="2">Province d'Anvers</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Hens, Niel" sort="Hens, Niel" uniqKey="Hens N" first="Niel" last="Hens">Niel Hens</name>
<affiliation wicri:level="4">
<nlm:affiliation>Centre for Health Economics Research & Modeling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Centre for Health Economics Research & Modeling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp</wicri:regionArea>
<orgName type="university">Université d'Anvers</orgName>
<placeName>
<settlement type="city">Anvers</settlement>
<region>Région flamande</region>
<region type="district" nuts="2">Province d'Anvers</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Beutels, Philippe" sort="Beutels, Philippe" uniqKey="Beutels P" first="Philippe" last="Beutels">Philippe Beutels</name>
<affiliation wicri:level="4">
<nlm:affiliation>Centre for Health Economics Research & Modeling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Centre for Health Economics Research & Modeling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp</wicri:regionArea>
<orgName type="university">Université d'Anvers</orgName>
<placeName>
<settlement type="city">Anvers</settlement>
<region>Région flamande</region>
<region type="district" nuts="2">Province d'Anvers</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">BMC infectious diseases</title>
<idno type="eISSN">1471-2334</idno>
<imprint>
<date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Disease Transmission, Infectious (economics)</term>
<term>Disease Transmission, Infectious (prevention & control)</term>
<term>Epidemics</term>
<term>Humans</term>
<term>Models, Theoretical</term>
<term>Terminology as Topic</term>
<term>Vaccines (therapeutic use)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Humains</term>
<term>Modèles théoriques</term>
<term>Terminologie comme sujet</term>
<term>Transmission de maladie infectieuse ()</term>
<term>Transmission de maladie infectieuse (économie)</term>
<term>Vaccins (usage thérapeutique)</term>
<term>Épidémies</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="economics" xml:lang="en">
<term>Disease Transmission, Infectious</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Disease Transmission, Infectious</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Vaccins</term>
</keywords>
<keywords scheme="MESH" qualifier="économie" xml:lang="fr">
<term>Transmission de maladie infectieuse</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Epidemics</term>
<term>Humans</term>
<term>Models, Theoretical</term>
<term>Terminology as Topic</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Humains</term>
<term>Modèles théoriques</term>
<term>Terminologie comme sujet</term>
<term>Transmission de maladie infectieuse</term>
<term>Épidémies</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Individual-based models (IBMs) are useful to simulate events subject to stochasticity and/or heterogeneity, and have become well established to model the potential (re)emergence of pathogens (e.g., pandemic influenza, bioterrorism). Individual heterogeneity at the host and pathogen level is increasingly documented to influence transmission of endemic diseases and it is well understood that the final stages of elimination strategies for vaccine-preventable childhood diseases (e.g., polio, measles) are subject to stochasticity. Even so it appears IBMs for both these phenomena are not well established. We review a decade of IBM publications aiming to obtain insights in their advantages, pitfalls and rationale for use and to make recommendations facilitating knowledge transfer within and across disciplines.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
<PMID Version="1">28893198</PMID>
<DateCompleted>
<Year>2018</Year>
<Month>03</Month>
<Day>05</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>12</Month>
<Day>02</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">1471-2334</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>17</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2017</Year>
<Month>09</Month>
<Day>11</Day>
</PubDate>
</JournalIssue>
<Title>BMC infectious diseases</Title>
<ISOAbbreviation>BMC Infect. Dis.</ISOAbbreviation>
</Journal>
<ArticleTitle>Lessons from a decade of individual-based models for infectious disease transmission: a systematic review (2006-2015).</ArticleTitle>
<Pagination>
<MedlinePgn>612</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-017-2699-8</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND">Individual-based models (IBMs) are useful to simulate events subject to stochasticity and/or heterogeneity, and have become well established to model the potential (re)emergence of pathogens (e.g., pandemic influenza, bioterrorism). Individual heterogeneity at the host and pathogen level is increasingly documented to influence transmission of endemic diseases and it is well understood that the final stages of elimination strategies for vaccine-preventable childhood diseases (e.g., polio, measles) are subject to stochasticity. Even so it appears IBMs for both these phenomena are not well established. We review a decade of IBM publications aiming to obtain insights in their advantages, pitfalls and rationale for use and to make recommendations facilitating knowledge transfer within and across disciplines.</AbstractText>
<AbstractText Label="METHODS">We systematically identified publications in Web of Science and PubMed from 2006-2015 based on title/abstract/keywords screening (and full-text if necessary) to retrieve topics, modeling purposes and general specifications. We extracted detailed modeling features from papers on established vaccine-preventable childhood diseases based on full-text screening.</AbstractText>
<AbstractText Label="RESULTS">We identified 698 papers, which applied an IBM for infectious disease transmission, and listed these in a reference database, describing their general characteristics. The diversity of disease-topics and overall publication frequency have increased over time (38 to 115 annual publications from 2006 to 2015). The inclusion of intervention strategies (8 to 52) and economic consequences (1 to 20) are increasing, to the detriment of purely theoretical explorations. Unfortunately, terminology used to describe IBMs is inconsistent and ambiguous. We retrieved 24 studies on a vaccine-preventable childhood disease (covering 7 different diseases), with publication frequency increasing from the first such study published in 2008. IBMs have been useful to explore heterogeneous between- and within-host interactions, but combined applications are still sparse. The amount of missing information on model characteristics and study design is remarkable.</AbstractText>
<AbstractText Label="CONCLUSIONS">IBMs are suited to combine heterogeneous within- and between-host interactions, which offers many opportunities, especially to analyze targeted interventions for endemic infections. We advocate the exchange of (open-source) platforms and stress the need for consistent "branding". Using (existing) conventions and reporting protocols would stimulate cross-fertilization between research groups and fields, and ultimately policy making in decades to come.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Willem</LastName>
<ForeName>Lander</ForeName>
<Initials>L</Initials>
<Identifier Source="ORCID">0000-0002-9210-1196</Identifier>
<AffiliationInfo>
<Affiliation>Centre for Health Economics Research & Modeling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium. lander.willem@uantwerp.be.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Verelst</LastName>
<ForeName>Frederik</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Centre for Health Economics Research & Modeling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bilcke</LastName>
<ForeName>Joke</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Centre for Health Economics Research & Modeling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hens</LastName>
<ForeName>Niel</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Centre for Health Economics Research & Modeling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Interuniversity Institute for Biostatistics and statistical Bioinformatics, UHasselt, Hasselt, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Beutels</LastName>
<ForeName>Philippe</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Centre for Health Economics Research & Modeling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>School of Public Health and Community Medicine, The University of New South Wales, Sydney, Australia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D017418">Meta-Analysis</PublicationType>
<PublicationType UI="D000078182">Systematic Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2017</Year>
<Month>09</Month>
<Day>11</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>BMC Infect Dis</MedlineTA>
<NlmUniqueID>100968551</NlmUniqueID>
<ISSNLinking>1471-2334</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014612">Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D018562" MajorTopicYN="Y">Disease Transmission, Infectious</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058872" MajorTopicYN="N">Epidemics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008962" MajorTopicYN="Y">Models, Theoretical</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009626" MajorTopicYN="N">Terminology as Topic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014612" MajorTopicYN="N">Vaccines</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="Y">Agent-based</Keyword>
<Keyword MajorTopicYN="Y">Dynamics</Keyword>
<Keyword MajorTopicYN="Y">Emerging diseases</Keyword>
<Keyword MajorTopicYN="Y">Endemic diseases</Keyword>
<Keyword MajorTopicYN="Y">Individual-based</Keyword>
<Keyword MajorTopicYN="Y">Mathematical epidemiology</Keyword>
<Keyword MajorTopicYN="Y">Modeling</Keyword>
<Keyword MajorTopicYN="Y">Networks</Keyword>
<Keyword MajorTopicYN="Y">ODD protocol</Keyword>
<Keyword MajorTopicYN="Y">Transmission</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2016</Year>
<Month>11</Month>
<Day>25</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2017</Year>
<Month>08</Month>
<Day>22</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2017</Year>
<Month>9</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2017</Year>
<Month>9</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2018</Year>
<Month>3</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">28893198</ArticleId>
<ArticleId IdType="doi">10.1186/s12879-017-2699-8</ArticleId>
<ArticleId IdType="pii">10.1186/s12879-017-2699-8</ArticleId>
<ArticleId IdType="pmc">PMC5594572</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>J R Soc Interface. 2010 Sep 6;7(50):1247-56</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20504800</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Health Aff (Millwood). 2016 Feb;35(2):199-207</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26858370</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Elife. 2015 Jul 11;4:null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26259874</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2014 Nov 1;210 Suppl 1:S424-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25316864</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Euro Surveill. 2014 Oct 23;19(42):null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25358040</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2015 Feb 02;10(2):e0116618</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25642941</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Health Care Manag Sci. 2016 Mar;19(1):1-19</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24710651</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Public Health. 2011 Feb 25;11 Suppl 1:S1</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21356128</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>F1000Prime Rep. 2014 Jun 02;6:39</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24991416</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Curr. 2013 Jun 21;5:null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23873050</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2015 Jun 27;385(9987):2571</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26122153</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2006 Jul 27;442(7101):448-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16642006</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Acta Trop. 2014 Jan;129:61-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23958228</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Bioinformatics. 2015 Jun 02;16:183</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26031500</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J R Soc Interface. 2008 Jan 6;5(18):67-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17504737</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2013 Aug 20;31(37):3863-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23830974</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Public Health. 2015 Mar;105(3):e20-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25602871</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2009 May 7;360(19):1981-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19420367</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J R Soc Interface. 2016 Dec;13(125):null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28003528</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Epidemics. 2011 Jun;3(2):95-102</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21624780</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Med. 2012 Dec 13;10:165</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23237460</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Negl Trop Dis. 2013;7(1):e2032</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23383355</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J R Soc Interface. 2015 Mar 6;12 (104):20141317</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25673302</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Infect Dis. 2014 May 21;14:280</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24886054</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Health Aff (Millwood). 2016 Feb;35(2):212-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26858372</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Theor Biol. 2006 Aug 7;241(3):477-87</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16427654</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Public Health. 2015 Sep;105(9):e42-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26180973</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Public Health. 2013 Oct 08;13:940</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24103508</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Epidemiol Infect. 2011 Jun;139(6):836-48</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20619075</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Infect Dis. 2010 Jun 29;10:190</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20587041</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Comput Biol. 2010 Apr 08;6(4):e1000736</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20386735</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Bull Med Libr Assoc. 1963 Jan;51:114-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">13982385</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Infect Dis. 2015 Jul 30;15:300</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26223223</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Epidemics. 2016 Dec 16;:null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28038870</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Risk Anal. 2016 Jul;36(7):1404-17</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26103154</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2015 Dec 17;10(12):e0144137</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26679499</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Infect Dis. 2013 Jun 28;13:294</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23809195</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2014 Dec 01;9(12):e113538</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25437014</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Phys Rev E Stat Nonlin Soft Matter Phys. 2011 Mar;83(3 Pt 2):037101</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21517627</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Negl Trop Dis. 2012;6(10):e1876</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23145197</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Infect Dis. 2008 Jun 17;8:83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18559109</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Comput Sci. 2010 Aug 1;1(3):132-145</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21415939</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virulence. 2010 Jul-Aug;1(4):338-49</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21178467</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>AMIA Annu Symp Proc. 2011;2011:161-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22195067</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Malar J. 2015 Jun 03;14:231</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26037226</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2012;7(7):e39927</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22808073</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Med. 2015 Mar 10;13:49</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25857701</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2010 Jul 12;28(31):4875-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20483192</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Epidemiol Infect. 2014 Jun;142(6):1245-58</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23925059</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4639-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18332436</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Value Health. 2011 Dec;14(8):1028-38</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22152171</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Med Microbiol Immunol. 2016 Jun;205(3):201-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26935826</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Malar J. 2012 Oct 29;11:357</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23107070</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sex Transm Infect. 2008 Oct;84 Suppl 2:ii12-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18799486</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Infect Dis. 2015 Feb;15(2):204-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25575618</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Curr. 2015 Mar 09;7:null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26064785</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Infect Control Hosp Epidemiol. 2009 Nov;30(11):1084-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19785517</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Theor Biol. 2015 Jan 7;364:266-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25264265</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Intern Med. 2009 Aug 18;151(4):264-9, W64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19622511</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2012;7(11):e48695</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23155399</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Theor Biol. 2011 Nov 21;289:197-205</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21906603</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Commun. 2015 Sep 08;6:8170</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26348689</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Comput Biol. 2010 Jan 29;6(1):e1000656</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20126529</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Public Health. 2015 May 01;15:447</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25928152</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMJ Open. 2013 Mar 26;3(3):null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23535701</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int Health. 2015 Mar;7(2):107-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25733560</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Med. 2015 Jul 29;13:170</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26219380</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatrics. 2016 Apr;137(4):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26993129</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Med. 2008 Mar 25;5(3):e74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18366252</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2011 Jan 31;6(1):e16591</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21304943</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Acad Emerg Med. 2006 Nov;13(11):1142-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17085740</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J R Soc Interface. 2013 Aug 28;10(88):20130613</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23985734</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Rep. 2015 Dec 14;5:18062</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26658016</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2008 Jul 16;3(7):e2661</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18628828</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2013;8(2):e56079</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23457504</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2010 Oct 15;5(10):e13392</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20976213</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Infect Dis. 2014 Aug 20;14:447</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25139524</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Math Biol. 2015 Oct;71(4):961-77</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25326654</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Comput Biol. 2011 Jul;7(7):e1002105</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21814504</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Theor Biol. 2009 Aug 7;259(3):478-88</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19361529</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Bull Math Biol. 2006 Nov;68(8):1893-921</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17086489</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Comput Biol. 2014 Apr 17;10(4):e1003563</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24743387</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J R Soc Interface. 2008 Feb 6;5(19):171-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17638650</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5935-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16585506</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Biol Sci. 2013 Oct 02;280(1771):20131939</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24089337</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sex Transm Infect. 2007 Aug;83 Suppl 1:i5-16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17405781</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2014 Aug 11;32 Suppl 1:A151-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25091670</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Health Geogr. 2009 Aug 05;8:50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19656403</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2011 Aug 6;378(9790):515-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21481448</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Epidemics. 2015 Mar;10:78-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25843389</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pharmacoeconomics. 2011 May;29(5):371-86</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21504239</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2009;4(5):e5439</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19415113</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Infect Dis. 2010 Jul 27;10:221</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20659348</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Belgique</li>
</country>
<region>
<li>Province d'Anvers</li>
<li>Région flamande</li>
</region>
<settlement>
<li>Anvers</li>
</settlement>
<orgName>
<li>Université d'Anvers</li>
</orgName>
</list>
<tree>
<country name="Belgique">
<region name="Région flamande">
<name sortKey="Willem, Lander" sort="Willem, Lander" uniqKey="Willem L" first="Lander" last="Willem">Lander Willem</name>
</region>
<name sortKey="Beutels, Philippe" sort="Beutels, Philippe" uniqKey="Beutels P" first="Philippe" last="Beutels">Philippe Beutels</name>
<name sortKey="Bilcke, Joke" sort="Bilcke, Joke" uniqKey="Bilcke J" first="Joke" last="Bilcke">Joke Bilcke</name>
<name sortKey="Hens, Niel" sort="Hens, Niel" uniqKey="Hens N" first="Niel" last="Hens">Niel Hens</name>
<name sortKey="Verelst, Frederik" sort="Verelst, Frederik" uniqKey="Verelst F" first="Frederik" last="Verelst">Frederik Verelst</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000876 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000876 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    StressCovidV1
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:28893198
   |texte=   Lessons from a decade of individual-based models for infectious disease transmission: a systematic review (2006-2015).
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:28893198" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a StressCovidV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed May 6 16:44:09 2020. Site generation: Sun Mar 28 08:26:57 2021